Founded in Atlanta, Sensiotec Inc. is dedicated to revolutionizing healthcare through its non-contact remote patient monitoring platforms. The company's core mission is to enhance patient care by providing continuous, critical cardiorespiratory data without the need for physical contact. Sensiotec's flagship product, Preventa™, utilizes ultra-wideband (UWB) technology to monitor heart and respiration rates, bed occupancy, and movement, delivering real-time data to healthcare providers via nurse stations, tablets, smartphones, or pagers.
Sensiotec has achieved significant milestones, including receiving FDA (k) Class II clearance for its innovative UWB monitoring device. This recognition underscores the company's commitment to advancing medical technology and improving patient outcomes. With a focus on non-invasive monitoring solutions, Sensiotec has garnered attention from notable investors and healthcare professionals, positioning itself as a leader in the remote patient monitoring market.
